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The present study forecasts the extensive damage caused by radiotherapy and 
chemotherapy treatment for cancer in the genetic setup of an individual. To 
counteract this damage, radioprotective potentiality of 50% Methanolic extract 
of Adhatoda vasica was evaluated through Cyto-Geno analysis. 
50% Methanolic extract of Adhatoda vasica leaves was used as a drug whose 
radioprotective potentiality was to be investigated. Human peripheral 
lymphocytes were cultured using RPMI-1640 media, harvested and observed 
under microscope for chromosomal aberration assay. 
Total 200 metaphases were counted for each group. All the metaphases were 
found to be normal in Control group. The frequency of normal metaphases 
greatly increased after pretreatment with both low and high drug dose (50mg/Kg 
body weight and 100mg/Kg body weight) concentration. The average normal 
metaphase in Radiation Control was 118 out of 200 metaphases but after 
pretreatment with 50% Methanolic extract of Adhatoda vasica the number of 
normal metaphase increased to 179 at 50mg/Kg body weight and 184 at 
100mg/Kg body weight. It was concluded that 50% Methanolic Extract of 
Adhatoda vasica with both low and high drug doses have shown its potentiality 
as a radio protector against the therapeutically induced mutations which can 
prove to be a contributor in cancer management in future. Such indigenous 
Indian, herbal, cost effective, poor man friendly drug will definitely be a 
potential adjuvant to cancer treatments like radiotherapy and chemotherapy 
since Amifostine a well known radioprotector given to the patients at the time of 
cancer therapy is expensive and has its own side effects. 
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Introduction  
Herbs have been used for time uncounted for 
healing the sick and infirm [1]. No doubt Indian 
herbs are the most sought after herbs in the world 
due to their organic quality, purity and lowest 
cost of cultivation. Cancer is one of the most 
dreaded diseases of the 20th century and 
spreading further with continuance and increasing 
incidence in 21st century [2].  
 
 
At the moment, most successful cancer therapy is 
done by radiation (radiotherapy) in spite of the 
fact that radiation is hazardous to health. DNA is 
considered to be the prime target of radiation 
action in the cells [3]. To increase the therapeutic 
index of radiation therapy, various modes of 
radioprotection have been developed that 
selectively reduce cytotoxic effects to normal 
tissues. Radioprotection is the protection of 
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normal cells from hazardous effects of ionizing 
radiation and the agents used for this purpose are 
known as radioprotectors.  Chemical 
radioprotectors may involve sulfhydryl 
radioprotecting compounds like Amifostine, [4-9] 
MEA (Mercaptoethylene amine), AET 
(Aminoethyl isothiourea)] free radical scavengers 
and antioxidants like ethanol, ethylene glycol, 
glycerol, vitamin A, C and E[10-11] etc. are 
found to be good radioprotectors. Chromosomal 
aberration study in animals is recognized as one 
of the most important sensitive parameters in 
assessing radiation damage and toxic effects as 
very small dose can produce detectable 
chromosome changes. Chromosomal aberrations 
may be numerical or structural. Structural 
aberrations may involve breaks, 
intrachromosomal exchange, deletion, interstitial 
deletion, rings, interchromosomal exchange, 
dicentrics, isochromosome, insertion, duplication, 
double minutes, and Micronuclei etc. [12-13] 
Adhatoda vasica a small evergreen sub-
herbaceous bush belonging to family 
Acanthaceae has been selected for our study to 
investigate the radioprotective potentiality. It’s a 
small evergreen sub herbaceous bush having 
many medicinal properties of importance like 
anti-diabetic, anti-asthmatic, anti-bacterial, 
diuretic, anti-inflammatory etc.   
 
Materials and Methods 
50% Methanolic extract of Adhatoda vasica 
leaves was prepared and used as a drug whose 
radioprotective potentiality was to be 
investigated. Human peripheral lymphocytes 
were cultured using RPMI-1640 media and 
harvested. Slides were prepared by Air drop 
technique, stained with Giemsa and observed 
under microscope for chromosomal aberration 
assay. To evaluate the radioprotective 
potentiality, four groups were taken viz. Control, 
Radiation Control, Drug Control and 
Drug+Radiation. Control group consisted of only 
blood without any radiation and without any 
drug. Radiation Control group consisted of blood 
plus radiation where peripheral lymphocytes were 
irradiated by Cobalt 60- γ radiation source with 
radiation doses ranging from 1Gray (RG1), 2 
Gray (RG2), 4 Gray (RG4), 6 Gray (RG6) and 9 
Gray (RG9) respectively. Drug control group 
consisted of blood plus drug. Drug dose was 
calculated according to 50mg/Kg body weight 
(D1) and 100mg/Kg body weight (D2) 
respectively. Drug + Radiation group where 
peripheral lymphocytes were pretreated with the 
drug before irradiation consisted of following sub 
groups: DRA1 (1Gray + 50mg), DRA2 (1Gray + 
100mg), DRB1 (2Gray + 50mg), DRB2 (2Gray + 
100mg), DRC1 (4 Gray + 50mg), DRC2 (4Gray 
+ 100mg), DRD1 (6Gray + 50mg), DRD2 (6Gray 
+ 100mg), DRE1 (9Gray + 50mg) and DRE2 
(9Gray + 100mg). 
 
Observation and Result 
Total 200 metaphases were counted for each 
group. All the metaphases were found to be 
normal in Control group. In Radiation Control 
group the percentage of aberrant metaphases was 
found to be as following: RG1-8%, RG2- 28%, 
RG4 -44%, RG6-60% and RG9-65% 
respectively. In Drug Control group for both D1 
and D2 sub groups percentage of aberrant 
metaphases was found to be similar i.e. 6%. In 
Drug + Radiation group the aberrant metaphases 
were found to be in following percentage: Sub 
group DRA1- 1%, DRA2- 5%, DRB1- 3%, 
DRB2- 7%, DRC1-7%, DRC2- 1%, DRD1-10%, 
DRD2 -7%, DRE1- 13% and DRE2 20% 
respectively. In our study the induction of 
Micronuclei in the experimental group was also 
observed as it is an indirect evidence of strand 
breaks, fragments and deletions in the 
chromosomes. 
 
Discussion and Conclusion 
In the present study a dose dependent 
radioprotection was obtained in all the 5 doses of 
radiation (1Gray, 2Gray, 4Gray, 6Gray and 
9Gray). When compared to the Radiation control 
group (radiation alone) the frequency of normal 
metaphases greatly increased after pretreatment 
with low drug dose (50mg/Kg body weight) 
concentration. Good metaphase index was shown 
by normal metaphases at high drug dose 
(100mg/Kg body weight), however in 1Gray,  


































































































TM NM AM TYPES OF ABERRATIONS GROUPS  
   DC  MIN  PCD  FBD  PP  BB  RG  ER  OT  
CT  C  200  200  0 0 0 0 0 0 0 0  0  0  
RG1  200  184  16 4 2 2 1 1 0 1  0  0  
RG2  200  144  56 30 10 16 4 2 4 6  1  2  
RG4  200  112  88 40 21 26 13 4 10 6  0  1  
RG6  200  80  120 70 28 46 13 16 1 14  2  10  
RC  
RG9  200  70  130 80 28 54 16 26 0 32  6  10  
D1  200  188  12 8 0 1 1 1 1 0  1  0  DC  
D2  200  188  12 6 0 1 1 1 1 0  1  0  
DRA1  200  198  2 0 0 1 0 0 0 1  0  0  
DRA2  200  190  8 2 0 2 0 0 0 6  0  0  
DRB1  200  194  6 2 2 0 0 2 0 0  0  0  
DRB2  200  186  14 2 0 6 4 0 0 2  2  4  
DRC1  200  186  14 8 2 0 0 2 0 6  0  2  
DRC2  200  198  2 0 0 0 0 0 0 0  2  0  
DRD1  200  180  20 2 4 6 4 4 0 6  2  2  
DRD2  200  186  14 2 0 0 0 4 0 12  0  0  
DRE1  200  174  26 4 2 2 4 4 0 12  0  0  
DR  
DRE2  200  160  40 6 22 6 4 4 0 22  0  4  
TM-Total metaphase, NM-Normal metaphase,  AM-Aberrated metaphase, DC-Dicentric, MIN-Minute, PCD-
Premature Centromeric Division, FBD-Fragment Break Deletion, PP-Polyploidy, BB-Bubbling, RG-Ring, 
ER-Endoreduplication, OT-Other 
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Fig 1: Comparision of Average of control, Radiation, Drug & Drug+ Radiation  
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Fig 2: Plates showing metaphase, CT- Control Group Showing Normal metaphase, RC- Radiation 
Control plate showing Tricentric (TC), Ring (RG) and fragment (FG) in radiated lymphocytes, DC- Drug 
control plate showing normal metaphase, D+R-Drug+Radiation plate showing normal metaphase 
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2Gray and 9Gray there was a slight deviation in 
normal metaphase count as compared to the 
50mg/Kg body weight concentration with mean 
and standard error values as 47.5±1.19 for 
1Gray, 46.5±1.25 for 2Gray, 49.5±0.28 for 
4Gray, 46.5±1.5 for 6Gray and 40±3.46 for 
9Gray. The survival percentage in the Drug 
control group was similar in both the drug doses 
(50 and 100mg/Kg body weight). The Dicentrics 
and similar other aberrations were reduced to a 
minimal percentage after pretreatment with drug 
before irradiation in comparison to Radiation 
control group.  
Populations of cancer patients undergoing cancer 
treatment by radiotherapy and chemotherapy are 
still in the high risk factor group for therapy 
induced mutations. Therefore complementary 
and alternative medicine is proving to be a better 
cure to minimize the side effects. Thus it is 
concluded that 50% Methanolic Extract of 
Adhatoda vasica with both low and high drug 
doses have shown its potentiality as a radio 
protector against the therapeutically induced 
mutations which can prove to be a contributor in 
cancer management in future. Such indigenous 
Indian, herbal, cost effective, poor man friendly 
drug will definitely be a potential adjuvant to 
cancer treatments like radiotherapy and 
chemotherapy since Amifostine a well known 
radioprotector given to the patients at the time of 
cancer therapy is expensive and has its own side 
effects. 
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